Short paperOptimization and validation of ELISA immunoassay for the evaluation of in-vitro relative potency of a four-component human papillomavirus vaccine products
Keywords: Human papillomavirus vaccine; Virus-like particles (VLP); ELISA; In-vitro relative potency; Validation; Desorption;